A trial to determine the effects of reduced intra-abdominal pressure (IAP) on obesity Co-morbidity. Severe obesity has become an epidemic problem in the United States as well as world-wide, and is associated with a number of morbid conditions which produce enormous health-care costs and work disability. Some of the problems caused by obesity are intra-abdominal pressure, urinary bladder pressure, breathing problems, gastroesophageal reflux, high blood pressure, and possibly, type II diabetes. This study will determine if an external device, which can lower intra-abdominal pressure, can be safely used and if it will reverse the physical problems caused by obesity. Also, the study will determine if using the device while sleeping 1/3 to = of the day will lower the long-term intensity of these problems. Patients with the previous list of problems caused by obesity who are being evaluated for a gastric procedure to treat severe obesity will be asked to participate in this study. Patients will be admitted to the CRC. Baseline studies of blood pressure, blood and urine tests will be done on the first day of the visit. On the second day a catheter will be inserted into the bladder to measure pressure and to collect urine. Patients will be randomly assigned to the group using the external device (The ABSHELL), or to a control group or non-treatment group. This will determine if rest alone in a non-stressful environment is as effective as the use of the device. Those randomized to use the device will have it placed on the abdomen and a vacuum applied until the bladder pressure is decreased toward a level seen in non-obese individuals. The device will be worn continuously for the next four days and released only for meals and use of the bathroom. Blood will be obtained during the study. Blood pressure and pulse rate will be frequently measured during the use of the ABSHELL and the negative pressure reduced or released if severe discomfort or a marked fall in blood pressure develops. Non-invasive ultrasound will be used to measure some large blood vessels in the neck and leg and to measure their rate of blood flow. During the second week of the study, patients will be asked to wear the ABSHELL at night while sleeping. Based upon a previous pilot study, most patients feel more comfortable in the ABSHELL, feeling less bloated, breathing more easily, and sleeping more easily.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
2000
Total Cost
$648
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications